All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention CorMedix Inc., the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Acorn Energy, Inc.
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention CorMedix Inc., the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window. At 5, the average consequence score sits below the same-window beat average of 5.8. We currently track 1 Healthcare story that mention Acorn Energy, Inc., all published on March 6, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Acorn Energy, Inc.. Shared-story counts are live from our verified record — not editorial picks.
CorMedix and Acorn Energy reported strong Q4 2025 results, highlighting a year of significant commercial expansion for specialized healthcare and infrastructure solutions. CorMedix saw accelerated adoption of its antimicrobial catheter lock solution, DefenCath, while Acorn Energy’s OmniMetrix division capitalized on rising demand for remote monitoring in critical healthcare facilities.
